NASDAQ OMX

Former First Sea Lord of the British Royal Navy, Admiral Sir George Zambellas, to Join Liquid Robotics' Strategic Advisory Board

Del

SUNNYVALE, Calif., 2017-03-29 13:00 CEST (GLOBE NEWSWIRE) -- Liquid Robotics® is honored to announce Admiral (ret.) Sir George Zambellas, the former First Sea Lord of the British Royal Navy, will join Liquid Robotics’ global Strategic Advisory Board. As a member of this distinguished board of advisors, Sir George will bring his vast military and maritime domain knowledge to help Liquid Robotics explore and develop new relationships and opportunities in the military and the non-military markets globally.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/ae12c6e7-254a-4490-b10f-75ec18661c1e

"I'm delighted to be able to support Liquid Robotics,” said Sir George Zambellas. “This responsibility will hit the sweet spot for me, combining deceptively advanced technology with extraordinary development potential, in the challenging underwater domain but with access to land, air and space, in a product range with global reach and global relevance - run by a small committed team."

A champion of technological innovation, and a pioneer of unmanned systems in maritime operations, Sir George has led the exploitation of autonomous systems for naval operations. As the First Sea Lord, he was the force behind Unmanned Warrior 2016, the first multi-national exercise of a real-life, large-scale interoperability of unmanned and autonomous systems. Lauded as ground breaking, it was during this exercise where Boeing and Liquid Robotics demonstrated the first time that a network of persistent USVs were able to detect, track and report a live submarine in a naval demonstration.

“We are honored to be welcoming Sir George Zambellas to our Strategic Advisory Board,” said Gary Gysin, President & CEO, Liquid Robotics. “We’ve admired Sir George’s leadership in challenging the world’s navies to think differently, to use advanced technologies, and unmanned systems to advance naval superiority. His expertise will be invaluable as we work towards creating a seafloor to space network to monitor our ocean environment and its threats.”

Sir George Zambellas has a highly distinguished naval career that concluded in April 2016 after a three-year appointment as Britain’s First Sea Lord. During this time he served in the UK Amphibious Force, the UK Maritime Force, NATO 4-star Maritime Command and Fleet Command and UK Ministry of Defence positions. As captain of HMS Chatham he was deployed as part of Operation Palliser to Sierra Leone, earning the Distinguished Service Cross.

This appointment has been referred to the Office of the Advisory Committee on Business appointments in the UK and is being made in accordance with the Committee’s advice.

About Liquid Robotics, a Boeing Company:
Liquid Robotics designs and manufactures the Wave Glider, the first wave and solar powered unmanned ocean robots. With our partners we address many of the planet’s greatest challenges, by transforming how to assess, monitor, and protect the ocean. We solve critical problems for defense, commercial, and science customers. Visit www.liquid-robotics.com to learn more.

Liquid Robotics and Wave Glider are registered trademarks of Liquid Robotics, Inc., a wholly owned subsidiary of Boeing.

The photo is also available via AP PhotoExpress.

         For media questions, please contact: Joanne Masters at press@liquid-robotics.com.

Om NASDAQ OMX

NASDAQ OMX
NASDAQ OMX
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra NASDAQ OMX

Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra NASDAQ OMX

Concurrent Achieves Sales Milestone for Zephyr Transcode19.10.2017 15:35Pressemelding

Concurrent Customers Now Transcoding on Three Continents ATLANTA, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Concurrent (NASDAQ:CCUR), a global leader in storage, protection, transformation, and delivery of visual media assets, announced today that Zephyr Transcode, which Concurrent launched last year as an integral part of its content delivery network (CDN) solutions, is now deployed with customers in Asia, Europe and North America. The deployments already support thousands of on-demand assets being transcoded to multiple formats and bit-rates to support any place, any device content availability. Zephyr Transcode supports multiple formats and quality levels including H.264 (MPEG-4) and H.265 (HEVC), strengthening Concurrent customers' capability to provide high-quality standards-based streams to any device their end-users desire. Zephyr Transcode is software-based and capable of running in traditional Central Processing Units (CPU) as well as Gra

German Armed Forces Renews Contract for Hexagon Geospatial Products19.10.2017 15:11Pressemelding

Defense agency will work closely with Hexagon Geospatial Premium Partner for next two years NORCROSS, Ga., Oct. 19, 2017 (GLOBE NEWSWIRE) -- At the HxGN LOCAL Defense Summit, a conference dedicated to defense and security in Western Europe, Hexagon Geospatial announced that the Bundeswehr Geoinformation Centre (BGIC) recently renewed a large software maintenance contract for Hexagon Geospatial products. The two-year renewal is for more than 100 licenses, mainly within the GeoMedia and ImageStation product families. The contract also includes consulting for workflow optimization. The contract was issued to Geosystems, a Hexagon Geospatial Premium Partner, which will work closely with the local subsidiary of Hexagon Safety & Infrastructure in Bonn and Munich to support BGIC. "The strong Hexagon Geospatial partner network allows our defense customers to benefit from a unique pool of expertise and tradecraft in the areas of remote sensing, GIS, and photog

Novel Preclinical Research Tools Provide Humanized Immune Response to Advance Immunotherapeutic Development, Live Webinar Hosted by Crown Bioscience19.10.2017 14:00Pressemelding

SANTA CLARA, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces a live webinar to be presented by Dr. Michelle Mack, Director of Global Scientific Engagement, entitled "Beyond Syngeneics - Novel Tools for Addressing Human Specificity in Immuno-Oncology." Checkpoint inhibitors like anti-PD-1, anti-PD-L1, and anti-CTLA-4 have revolutionized cancer treatment and have recently gained approval in several cancer types. Despite their potential, immunotherapies face significant development challenges due to the specificity and complexity of the human immune system upon which they act. Crown Bioscience has generated innovative research models to address these obstacles early during preclinical drug development.

Perfectus Aluminum Inc. Responds to Trade Group19.10.2017 13:00Pressemelding

ONTARIO, Calif., Oct. 19, 2017 (GLOBE NEWSWIRE) -- Perfectus Aluminum Inc. has issued the following: On October 12, 2017 the Aluminum Extruders Council (AEC), an industry group representing largely American aluminum extruders, posted to its blog a false narrative regarding a suit to which Perfectus Aluminum Inc. is a related party. The government is not "seeking unpaid duties from Perfectus for goods brought into the country." Rather, the government is attempting to use a 2017 Department of Commerce determination to assess retroactive antidumping duties on goods imported as early as 2011. It is discouraging that AEC would tout such an obviously egregious government overstep as a "victory" to their members and the industry: were it one of AEC's own members facing such an obvious violation of fair play and due process, it would rightfully argue that government overreach is a threat to manufacturers everywhere. In addition to the hypocrisy of the AEC's promotion of this case, its s

Payvision's annual report reveals cross-border ecommerce trends in 201719.10.2017 09:00Pressemelding

With online marketplaces and consumer technology leading the way for growth AMSTERDAM, The Netherlands, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Payvision, global acquirer and data-driven omnichannel solutions provider, has published the findings of its fifth annual cross-border ecommerce research report, in collaboration with Juniper Research. The paper includes the results of a global survey of various industry players regarding the game-changers, the biggest challenges, the best practices for going cross-border, and much more. When compared to last year's findings, the report reveals a new and exciting context for global cross-border trade. The compound annual growth rate predicted for the next three years for cross-border ecommerce is now 17%, whereas it stands at just 12% for ecommerce overall. Also, over the past 12 months, merchants' attitudes towards cross-border ecommerce have become more positive, with 50% of respondents agreeing and 31% strongly

High Seizure Frequency in Children with Dravet Syndrome Negatively Impacts Quality of Life, New International Caregiver Survey Finds19.10.2017 08:00Pressemelding

Global survey of 584 caregivers of children, young adults and adults with Dravet illustrates the detrimental effect of debilitating, frequent seizures on quality of life and co-morbidities Results suggest a need for more effective antiepileptic treatments EMERYVILLE, Calif. and BREST, France, Oct. 19, 2017 (GLOBE NEWSWIRE) -- The Dravet Syndrome European Federation and Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, announced today the publication of the initial results from a landmark survey into the clinical, social and economic consequences of Dravet syndrome on children, young adults and their families in Developmental Medicine & Child Neurology [doi:10.1111/dmcn.13591]. This study was led by Lieven Lagae, M.D., Ph.D., Professor at the University of Leuven, Belgium, Head of the Pediatric Neurology Department and Director of the Childhood Epilepsy

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom